NAGENiagen Bioscience, Inc.vs its industry peers
A metric-by-metric comparison of Niagen Bioscience, Inc. against Medicinal Chemicals & Botanical Products — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NAGEEsta | $245M#4 | 16.3x#1 | 3.0x#6 | 1.9x#6 | 29.9%#3 | 103.3%#2 | 12.6%#2 | 21.1%#1 | — | 8#1 | -69.7%#8 | — |
| TRLV | $2.3B#1 | — | 2.8x#5 | 2.0x#7 | -0.4%#9 | 25.0%#6 | 12.1%#3 | -14.1%#5 | 0.0%#2 | — | — | — |
| TLRY | $579M#2 | — | 0.4x#1 | 0.6x#5 | 11.5%#4 | 94.4%#3 | -6.9%#6 | -7.5%#4 | -4.2%#3 | 4#3 | -64.4%#7 | — |
| USNA | $273M#3 | — | 0.5x#3 | 0.3x#4 | 8.3%#5 | -74.4%#11 | 4.0%#4 | 2.0%#3 | — | — | -50.3%#5 | — |
| FTLF | $88M#6 | 49.3x#2 | 1.9x#4 | 5.5x#8 | -75.3%#12 | -29.6%#8 | 18.6%#1 | 13.4%#2 | 3.0%#1 | 4#3 | -51.7%#6 | — |
| MTEX | $16M#7 | — | — | — | — | — | — | — | — | — | -10.3%#2 | — |
| NAII | $12M#8 | — | — | — | — | — | — | — | — | — | -45.3%#4 | — |
| CYAN | $3M#10 | — | 0.4x#2 | 0.1x#2 | 5.0%#6 | 39.2%#5 | -10.4%#7 | -39.7%#6 | -15.9%#5 | 5#2 | 0.0%#1 | — |
| MEHA | $1M#12 | — | — | 0.2x#3 | 0.7%#7 | 235.6%#1 | -21.2%#8 | — | — | — | — | — |
| SNYR | $1M#11 | — | — | 0.0x#1 | -12.8%#11 | -680.8%#13 | -27.8%#9 | — | — | 2#6 | -92.6%#9 | 84.7%#1 |
| AAWH | — | — | — | — | -10.9%#10 | -39.1%#10 | -3.4%#5 | — | -10.3%#4 | — | — | — |
| ACB | $238M#5 | — | — | — | — | — | — | — | — | — | -15.8%#3 | — |
| ADIA | — | — | — | — | 10879.7%#1 | -118.4%#12 | -52.3%#11 | — | — | — | — | — |
| AIBT | — | — | — | — | — | -19.9%#7 | -84501.7%#13 | — | — | — | — | — |
| AKAN | $6M#9 | — | — | 7.6x#9 | 97.5%#2 | 87.3%#4 | -523.8%#12 | — | — | — | -96.0%#10 | — |
| AYRWF | — | — | — | — | 0.0%#8 | -31.9%#9 | -34.7%#10 | -94.7%#7 | -21.8%#6 | 4#3 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2833). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-22.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice